Monte Rosa Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GLUE research report →
About the company
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins.
- CEO
- Markus Warmuth
- IPO
- 2021
- Employees
- 142
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $1.58B
- P/E
- -13.02
- P/S
- 36.71
- P/B
- 3.04
- EV/EBITDA
- -11.78
- Div Yield
- 0.00%
- Gross Margin
- 95.28%
- Op Margin
- -345.21%
- Net Margin
- -302.69%
- ROE
- -40.99%
- ROIC
- -21.82%
- Revenue
- $123.67M · 63.54%
- Net Income
- $-38,626,000 · 46.87%
- EPS
- $-0.46 · 53.06%
- Op Income
- $-54,208,000
- FCF YoY
- -172.35%
- 52W High
- $25.77
- 52W Low
- $4.12
- 50D MA
- $19.33
- 200D MA
- $16.62
- Beta
- 1.60
- Avg Volume
- 1.10M
Get TickerSpark's AI analysis on GLUE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Janku Filip | other | 5,407 |
| Jun 30, 26 | Janku Filip | other | 5,407 |
| Jun 30, 26 | Janku Filip | sell | 5,407 |
| Jun 29, 26 | Janku Filip | other | 6,000 |
| Jun 29, 26 | Janku Filip | other | 6,000 |
| Jun 29, 26 | Janku Filip | sell | 6,000 |
| Jun 29, 26 | Manning Anthony M. | other | 10,000 |
| Jun 29, 26 | Manning Anthony M. | other | 10,000 |
| Jun 29, 26 | Manning Anthony M. | sell | 10,000 |
| Jun 23, 26 | Janku Filip | other | 6,000 |
Our GLUE coverage
Recent articles, reports, and earnings notes.
No research on GLUE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GLUE report →Similar companies
Peers in the same neighborhood.